Stocks · Health care · Pharmaceutical Preparations

Amylyx Pharmaceuticals, Inc.

AMLX Clue Score40
United States Fiscal year ends December CIK 0001658551 Results filed 5 Nov 2026

What the insiders did No buying or selling

By person

8 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Joshua B Cohen
Co-Chief Executive Officer
—
—
—
3,613,123
$100.07M
+12.2%
Justin B. Klee
Co-Chief Executive Officer
—
—
—
3,613,056
$100.07M
+13.5%
George M Milne Jr
Director
—
—
—
782,881
$21.68M
−8.8%
Camille L Bedrosian
Chief Medical Officer
—
—
—
278,064
$7.70M
+93.4%
James M Frates
Chief Financial Officer
—
—
—
273,625
$7.58M
+105.0%
Gina Mazzariello
Chief Legal Officer
—
—
—
190,838
$5.29M
+33.7%
Karen Firestone
Director
—
—
—
116,900
$3.24M
+112.5%
Bernhardt G Zeiher
Director
—
—
—
10,000
$276.97K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.